Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03HJZ
|
||||
| Former ID |
DIB010858
|
||||
| Drug Name |
AZ-11657312
|
||||
| Synonyms |
AZ-11657312; P2X7 purinoceptor antagonists (inflammation); P2X7 purinoceptor antagonists (inflammation), AstraZeneca
|
||||
| Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [543850] | ||
| Company |
AstraZeneca plc
|
||||
| Canonical SMILES |
C12(CC(=O)Nc3cc4[nH]ncc4cc3)CC3CC(C2)CC(C1)C3
|
||||
| Target and Pathway | |||||
| Target(s) | P2X purinoceptor 7 | Target Info | Antagonist | [543850] | |
| Reactome | The NLRP3 inflammasome | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.